Clinical Trials Browser

Burkitt Lymphoma, Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Experimental, Recurrence, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT01279707 2014-07-14

MARALL

Phase 1/2 Unknown

55 enrolled

Lymphoid

Burkitt Lymphoma, Recurrence

NCT01010243 2012-05-30

MM03

Phase 1/2 Unknown

54 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT01385072 2011-11-16

Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies

Phase 1/2 Unknown

10 enrolled

Recurrence

NCT00635557 2011-03-25

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Phase 1/2 Unknown

30 enrolled

CNS

Glioblastoma, Recurrence

NCT01322776 2011-03-25

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma

Phase 1/2 Unknown

40 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

Clinical Trials

BORTEM-17

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

CT32

Lorlatinib Combinations in Lung Cancer

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma

CAR-T

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

TRANSATRA

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）

CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）

NKEXPGD2

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma

IDPR-HSCT

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

TMI-ASCT

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Treatment of Acute Leukemia Relapse After Allotransplantation

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

MARALL

MM03

Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma